Memantine hydrochloride oral
Memantine Hydrochloride is a prescription oral solution (2 mg/mL) used to treat moderate to severe Alzheimer's disease. It works by regulating glutamate activity in the brain. Manufactured by Seton Pharmaceuticals under ANDA210319. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Memantine Hydrochloride is a prescription oral solution (2 mg/mL) used to treat moderate to severe Alzheimer's disease. It works by regulating glutamate activity in the brain. Manufactured by Seton Pharmaceuticals under ANDA210319. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Memantine hydrochloride oral", "mediaType": "text/html", "description": " Access the FDA dataset for Memantine hydrochloride oral — ANDA 210319 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210319" } ] |
| identifier | ANDA210319 |
| issued | 2016-09-16 |
| keyword |
[ "drug", "drug-manufacturers", "drug-safety", "health-care", "medications" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Memantine hydrochloride oral |
